TrialPloS one2018
A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.
Hélène Blasco et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled itcites it